Teladoc's Stock Jumps on Barclays Coverage

Teladoc Healths shares surged by 2.8% in the morning, following Barclays Equal Weight rating and $8.50 price target, hinting at nearly 19% upside. However, the initial excitement faded, with shares settling at $7.52, still up 3.9% from the previous close. The stock has been volatile, down 21.1% this year, and trading 47.6% below its 52-week high, reflecting a notable but not game-changing impact on the companys outlook.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.